[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,665
  • Shares Outstanding, K 234,696
  • Annual Sales, $ 48,470 K
  • Annual Income, $ -170,370 K
  • EBIT $ -171 M
  • EBITDA $ -176 M
  • 60-Month Beta 2.15
  • Price/Sales 1.70
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.75
  • Most Recent Earnings $-0.21 on 03/17/26
  • Next Earnings Date 05/21/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 154.51% (-9.07%)
  • Historical Volatility 86.52%
  • IV Percentile 69%
  • IV Rank 15.70%
  • IV High 633.32% on 02/20/26
  • IV Low 65.36% on 08/20/25
  • Expected Move (DTE 7) 0.1190 (36.39%)
  • Put/Call Vol Ratio 0.74
  • Today's Volume 523
  • Volume Avg (30-Day) 339
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 75,143
  • Open Int (30-Day) 76,900
  • Expected Range 0.2080 to 0.4460

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.18
  • Number of Estimates 5
  • High Estimate $-0.05
  • Low Estimate $-0.25
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3250 +0.62%
on 05/08/26
0.4677 -30.08%
on 04/15/26
-0.0204 (-5.87%)
since 04/08/26
3-Month
0.3200 +2.19%
on 04/07/26
2.4950 -86.89%
on 02/13/26
-1.9330 (-85.53%)
since 02/06/26
52-Week
0.3200 +2.19%
on 04/07/26
3.8700 -91.55%
on 12/15/25
-0.7930 (-70.80%)
since 05/08/25

Most Recent Stories

More News
Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , May 8, 2026 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that investors with losses related to Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS ...

GOSS : 0.3270 (-4.86%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS).   Such investors...

GOSS : 0.3270 (-4.86%)
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Concealed PROSERA Placebo Risk: SueWallSt

Important Information Regarding Section 20(a) Individual Liability Claims

GOSS : 0.3270 (-4.86%)
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing PROSERA Trial Risks: Levi & Korsinsky

Key Dates and Disclosure Events Shareholders Need to Know

GOSS : 0.3270 (-4.86%)
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit

NEW YORK , May 5, 2026 /PRNewswire/ --

GOSS : 0.3270 (-4.86%)
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman

SAN FRANCISCO , May 5, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. ( NASDAQ: GOSS ) and an executive, seeking to represent investors who purchased...

GOSS : 0.3270 (-4.86%)
GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gossamer To Contact Him Directly To Discuss Their Options

GOSS : 0.3270 (-4.86%)
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit - Contact The Gross Law Firm

NEW YORK , May 5, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS).

GOSS : 0.3270 (-4.86%)
GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gossamer To Contact Him Directly To Discuss Their Options

GOSS : 0.3270 (-4.86%)
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit

NEW YORK , April 30, 2026 /PRNewswire/ --

GOSS : 0.3270 (-4.86%)

Business Summary

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology...

See More

Key Turning Points

3rd Resistance Point 0.3668
2nd Resistance Point 0.3581
1st Resistance Point 0.3425
Last Price 0.3270
1st Support Level 0.3182
2nd Support Level 0.3095
3rd Support Level 0.2939

See More

52-Week High 3.8700
Fibonacci 61.8% 2.5139
Fibonacci 50% 2.0950
Fibonacci 38.2% 1.6761
Last Price 0.3270
52-Week Low 0.3200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.